Foresite Capital Management II’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
2018
Q4
$4.03M Buy
2018
Q3
$6.78M Sell
2018
Q2
$8.31M Buy
2018
Q1
$4.49M Buy
2016
Q3
Sell
2016
Q2
$8.6M Sell
2016
Q1
$14.3M Hold
2015
Q4
$21.2M Buy
2015
Q3
$21M Hold
2015
Q2
$32.2M Buy